Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation

Despite the lack of statistical correlation between the variables analyzed, the role of PARP1 in BCR::ABL1 leukemia cannot be ruled out, given the instability profile promoted by this translocation. Finally, further studies involving a larger sample of patients are needed, as well as investigations into other molecular pathways that may impact on the pathogenesis of different BCR::ABL1 leukemic subtypes.

Authors

Institutions

Publication Details

Journal
Cancer Diagnosis & Prognosis
Published
2024-09-01
DOI
https://doi.org/10.21873/cdp.10368
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation

Maria Elisabete Amaral de Moraes, Aline Damasceno Seabra, Caroline Aquino Moreira-Nunes, Rommel Mário Rodríguez Burbano et al.
Cancer Diagnosis & Prognosis
PARP inhibition in cancer therapy
article

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation

Maria Elisabete Amaral de Moraes, Aline Damasceno Seabra, Caroline Aquino Moreira-Nunes, Rommel Mário Rodríguez Burbano, Jean Breno Silveira da Silva, André Salim Khayat, Flávia Melo Cunha de Pinho Pessoa, Fernando Augusto Rodrigues Mello Júnior, Caio Bezerra Machado, Deivide de Sousa Oliveira, Manoel Odorico de Moraes, Beatriz Maria Dias Nogueira, RODRIGO MONTEIRO RIBEIRO, Guilherme Passos de Morais
article en

Abstract

Despite the lack of statistical correlation between the variables analyzed, the role of PARP1 in BCR::ABL1 leukemia cannot be ruled out, given the instability profile promoted by this translocation. Finally, further studies involving a larger sample of patients are needed, as well as investigations into other molecular pathways that may impact on the pathogenesis of different BCR::ABL1 leukemic subtypes.

Cancer Diagnosis & PrognosisVol. 4(5)
Universidade Federal do Ceará (BR), Amazon Research Foundation (BR), Unichristus (BR), Hospital Geral de Fortaleza (BR), Universidade Federal do Pará (BR)
Conselho Nacional de Desenvolvimento Científico e Tecnológico
No poverty
Openalex Percentile: Top 75%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.